Potential for Nuclear Medicine Therapy for Glioblastoma Treatment

Clément Bailly, Aurelien Vidal, Coralie Bonnemaire, Françoise Kraeber-Bodéré, Michel Chérel, Amandine Pallardy, Caroline Rousseau, Emmanuel Garcion, Franck Lacoeuille, François Hindré, Samuel Valable, Myriam Bernaudin, Caroline Bodet-Milin, Mickaël Bourgeois

Open source

DOI: 10.3389/fphar.2019.00772
Published: 2019-07-10
Container: Frontiers in Pharmacology
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2019.00772,
  title = {Potential for Nuclear Medicine Therapy for Glioblastoma Treatment},
  author = {Clément Bailly and Aurelien Vidal and Coralie Bonnemaire and Françoise Kraeber-Bodéré and Michel Chérel and Amandine Pallardy and Caroline Rousseau and Emmanuel Garcion and Franck Lacoeuille and François Hindré and Samuel Valable and Myriam Bernaudin and Caroline Bodet-Milin and Mickaël Bourgeois},
  year = {2019},
  journal = {Frontiers in Pharmacology},
  doi = {10.3389/fphar.2019.00772},
  url = {https://doi.org/10.3389/fphar.2019.00772}
}

RIS

TY  - JOUR
TI  - Potential for Nuclear Medicine Therapy for Glioblastoma Treatment
AU  - Clément Bailly
AU  - Aurelien Vidal
AU  - Coralie Bonnemaire
AU  - Françoise Kraeber-Bodéré
AU  - Michel Chérel
AU  - Amandine Pallardy
AU  - Caroline Rousseau
AU  - Emmanuel Garcion
AU  - Franck Lacoeuille
AU  - François Hindré
AU  - Samuel Valable
AU  - Myriam Bernaudin
AU  - Caroline Bodet-Milin
AU  - Mickaël Bourgeois
PY  - 2019
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2019.00772
UR  - https://doi.org/10.3389/fphar.2019.00772
ER  -

APA

Bailly, C., Vidal, A., Bonnemaire, C., Kraeber-Bodéré, F., Chérel, M., Pallardy, A., Rousseau, C., Garcion, E., Lacoeuille, F., Hindré, F., Valable, S., Bernaudin, M., Bodet-Milin, C., & Bourgeois, M. (2019). Potential for Nuclear Medicine Therapy for Glioblastoma Treatment. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2019.00772

Source records

crossref · retrieved 2026-09-27T10:08:50.486Z